Dennis Patin, MD
Interventional Pain Medicine · Miami, FLNPI 1871528794
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Abbott at 42.9% of the total. Reporting peaked in 2019 at $56,432 and has fallen 90.6% since, to $5,311 in 2025. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 510 payments — averaging $178.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$39K
- Nevro Corp.$27K
- Medtronic$6K
- Boston Scientific$4K
- Saluda Medical Americas, Inc.$4K
- West Therapeutics Development, LLC$3K
- plus $8K from 19 others
What the payments were for
- Consulting fees$20,67523%
- Speaking & faculty fees$37,22841%
- Grants$2490%
- Travel & lodging$14,55016%
- Food & beverage$18,53320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 156 | $39,134 |
| Nevro Corp. | 74 | $27,340 |
| Medtronic(2 entities) | 31 | $6,420 |
| Boston Scientific | 127 | $4,031 |
| Saluda Medical Americas, Inc. | 27 | $3,983 |
| West Therapeutics Development, LLC | 1 | $2,500 |
| Stratus Medical, LLC | 10 | $1,586 |
| Nalu Medical, Inc. | 7 | $1,380 |
| Globus Medical | 13 | $1,370 |
| SPR Therapeutics, Inc | 31 | $1,190 |
| Si-bone, Inc. | 4 | $920 |
| Stimwave Technologies Incorporated | 3 | $445 |
| Biodelivery Sciences International, Inc. | 9 | $329 |
| Vertiflex, Inc. | 2 | $140 |
| Mentor Worldwide LLC | 1 | $115 |
| Tersera Therapeutics LLC | 4 | $110 |
| AbbVie | 2 | $53 |
| MML US, Inc. | 1 | $50 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Merit Medical Systems Inc | 1 | $29 |
| GRT US Holding, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Saol Therapeutics Inc. | 1 | $16 |
| Interventional Pain Technologies Inc. | 1 | $13 |
| Vertos Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neuromodulation Dspsbls and Accs$17,509
- Senza Spinal Cord Stimulation System$16,702
- Axium INS DRG IPG$15,050
- Omnia$8,802
- Proclaim Family of SCS IPGs$3,215
- Lazanda$2,500
- SYNCHROMED$2,500
- Evoke$2,205
- SYNCHROMEDII$1,849
- Senza$1,832
- Nimbus$1,536
- Evoke SCS$1,365
- Nalu Neurostimulation System$1,351
- ADAPTIVESTIM$1,250
- SPECTRA WAVEWRITER$1,172
- PROCLAIM$811
- SPRINT PNS System$734
- WAVEWRITER ALPHA$725
- WaveWriter Alpha Prime 16$271
- Protege Family of SCS IPGs$268
How this compares
$91,235 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 12 | $21,062 |
| BelbucaBuprenorphine Hcl | 29 | $20,351 |
| Buprenorphine | 44 | $11,708 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 221 | $11,191 |
| Xtampza ErOxycodone Myristate | 11 | $10,204 |
| Fentanyl | 43 | $5,075 |
| Oxycodone Hcl | 115 | $3,300 |
| Naloxone Hcl | 28 | $2,078 |
| Pregabalin | 65 | $1,696 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $1,297 |
| Tramadol Hcl ErTramadol Hcl | 18 | $1,005 |
| Morphine Sulfate | 18 | $857 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 23 | $798 |
| Hydromorphone Hcl | 34 | $744 |
| Tramadol Hcl | 84 | $602 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Belbuca, Xtampza Er | $17 | $51,61852 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Miami
- Javier VilasusoMiami$51K
- Joaquin Maury OchoaMiami$14K
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.